Browsing Journal Articles by Author "Haberer, JE"
Now showing items 1-3 of 3
-
HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.
Donnell, D; Baeten, JM; Bumpus, NN; Brantley, J; Bangsberg, DR; Haberer, JE; Mujugira, A; Mugo, N; Ndase, P; Hendrix, C; Celum, C (University of Nairobi, 2014)BACKGROUND: Antiretroviral pre-exposure prophylaxis (PrEP) is a novel HIV prevention strategy for which adherence is a known determinant of efficacy. Blood concentrations of PrEP medications are one objective marker of ... -
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.
Baeten, JM; Donnell, D; Mugo, NR; Ndase, P; Thomas, K; Campbell, J; Wangisi, J; Tappero, JW; Bukusi, EA; Cohen, CR; Katabira, E; Ronald, A; Tumwesigye, E; Were, E; Fife, KH; Kiarie, J; Farquhar, C; John-Stewart, G; Kidoguchi, L; Coombs, RW; Hendrix, C; Marzinke, MA; Frenkel, L; Haberer, JE; Bangsberg, D; Celum, C (2014)Abstract BACKGROUND: Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious ... -
Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.
Mugo, PM; Sanders, EJ; Mutua, G; van der Elst, E; Anzala, O; Barin, B; Bangsberg, DR; Priddy, FH; Haberer, JE (2014)A qualitative assessment of Kenyan men who have sex with men taking daily and intermittent oral HIV pre-exposure prophylaxis (PrEP) found stigma, sex work, mobility, and alcohol impacted adherence. We analyzed quantitative ...